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Abstract 
In adults, gender, aging, and obesity have been identified as prominent risk factors for 
impaired endothelium-independent dilation (EID). Whether, these factors impact EID in 
youth has not been well documented. Therefore, we examined how gender, age, pubertal 
status, and obesity influence endothelium-independent dilation (EID) in youth. Three 
hundred twenty-two healthy youth (142 females), ages 9 to 18 years (mean ± SEM, age = 
14.1 ± 0.14 years; body mass index percentile [BMI-percentile] = 70.0 ± 1.5 percentile) 
were included in this cross-sectional study. The change in brachial artery diameter 
following administration of 0.3 mg of sublingual nitroglycerin to induce EID was 
measured using a conventional ultrasound scanner (Acuson, Sequoia 512, Siemens 
Medical Solutions USA, Inc., Mountain View, CA, USA) with a 8-15 MHz linear array 
probe. Multiple linear regression models were created using gender, age, BMI-percentile, 
percent body fat and baseline diameter as predictor variables. Statistical analysis of 
pubertal status and BMI category was conducted using one-way ANOVA, adjusting for 
gender, age, BMI-percentile, race, and baseline diameter. Females had higher EID-area 
under the curve (EID-AUC) compared to males (p=0.012) but not EID% (p=0.112). Age 
was a significant predictor of EID% (β=0.37, p=0.04) and EID-AUC (β=83.5, p=0.02) in 
females but not in males (EID%, p=0.83; EID-AUC, p=0.92). No differences in EID% or 
EID-AUC were observed across Tanner stages. There were no differences in EID% or 
EID-AUC among normal-weight, overweight, and obese participants, and percent body 
fat was not a significant predictor of EID% or EID-AUC. These data suggest that gender 
differences in EID are apparent early in life, with aging-related changes observable in 
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females, but not males. Obesity does not appear to impact EID in children and 
adolescents. The mechanisms by which young males and females exhibit early 
differences in smooth muscle function require further investigation. 
 
Key Words: Smooth muscle function, Gender Differences, Pediatric, Cardiovascular 
Disease Risk, BMI  
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CHAPTER 1. INTRODUCTION 
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Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide 
(World Health Organization, 2013). The progression of CVD occurs over the course of 
the lifespan with its origins beginning in early life (Newman, Wattigney, & Berenson, 
1991). Regulation of vascular tone via vascular smooth muscle (VSM) is vital for normal 
arterial function (Falk, 2006). Dysfunction of the VSM represents a key step in the early 
stages of the atherosclerotic process (Rudijanto, 2007).  
 
A well-validated non-invasive measure of VSM function involves use of ultrasound 
imaging of the brachial artery following the administration of sublingual nitroglycerin 
(Corretti et al., 2002). Reduced amounts of this endothelium-independent dilation (EID) 
have been associated with many chronic diseases in adults including coronary artery 
disease (Heitzer, Schlinzig, Krohn, Meinertz, & Munzel, 2001), Type 1 (Johnstone et al., 
1993) and Type II (McVeigh et al., 1992) diabetes, and inflammatory bowel disease 
(Kayahan et al., 2012). Although there are numerous studies examining EID in healthy 
and diseased adults, there is a lack of information available on EID in children. 
 
In adults, males exhibit greater incidence of CVD (Lerner, Lerner, & Kannel, 1986) and 
reduced VSM function compared to females (Adams et al., 1998; McCue, Marlatt, Kelly, 
Steinberger, & Dengel, 2012; Thelen, Kelly, Williamson, & Dengel, 2008). Similar 
associations between gender and EID have not been verified in children, as minimal data 
on gender differences is available in this population (Jarvisalo et al., 2002). Aging is a 
primary contributor of VSM dysfunction which is caused by migration and proliferation 
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of smooth muscle cells (Herrera, Mingorance, Rodriguez-Rodriguez, & Alvarez de 
Sotomayor, 2010; Rudijanto, 2007). This phenomenon is mirrored in studies showing 
impairment of EID with increasing age in asymptomatic adults (Al-Shaer et al., 2006; 
Montero, Pierce, Stehouwer, Padilla, & Thijssen, 2014).  While most studies in children 
utilize age as a covariate in analysis, no formal study has shown whether age is associated 
with differences in EID in children and adolescents (Jarvisalo et al., 2002) and only one 
study has examined the impact of pubertal status of EID response (Marlatt et al., 2013). 
Moreover, obesity in childhood is known to play a key role in the development of many 
CVD risk factors. However, only limited data exist on the role of obesity and EID in 
children and adolescents (Jarvisalo et al., 2002; Pena et al., 2006).  
 
Examining the relationships between gender, age, pubertal status and obesity with EID in 
children and adolescents may provide insight into early progression of atherosclerosis. 
However, limited data is available on how these variables influence EID in youth. 
Therefore, the purpose of this study was to examine the association between gender, age, 
pubertal status, and obesity with EID in children and adolescents. 
 
The following chapters of this thesis include a review of literature, explanation of 
methods, summary of results, discussion and conclusion.  
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Chapter two provides a review of relevant literature related to the VSM function, 
influences of gender, age, pubertal status and adiposity on VSM function, and the use of 
EID as a validated measure of assessing vascular smooth muscle function non-invasively. 
  
Chapter three includes information on the methods and procedures utilized in this study. 
Additionally, information on study population, techniques and equipment, data collected 
and statistical analyses used are included. 
 
Chapter four summarizes the results of the study. Differences in EID between males and 
females, changes in EID across age, and comparison of EID between Tanner stages and 
BMI status are included.   
  
Chapter five includes discussion of study results. Associations between gender, age, 
pubertal status, adiposity, and EID are reviewed. Findings are presented in light of 
previously published studies on, and related to, the current topic.  
 
Chapter six provides final conclusions and clinical implications of the findings of this 
study. The significance of how certain clinical characteristics can influence EID in 
children is discussed along with recommendations for future studies.  
 
Chapter seven provides a list of all cited works. 
 
 
  5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2. LITERATURE REVIEW 
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The Endothelium and Vascular Smooth Muscle 
The vascular system is a dynamic network of vessels that transport blood to tissues and 
clears waste (Cines et al., 1998). Blood vessels are composed of three layers: the 
innermost layer, the tunica intima; the tunica media; and the outermost layer, the tunica 
externa. (Marieb & Hoehn, 2007). The tunica media of the blood vessel is composed 
primarily of vascular smooth muscle (VSM) and is responsible for maintaining vascular 
tone by contracting and relaxing in response to endogenous and exogenous stimuli 
(Rudijanto, 2007). VSM cells display a high degree of plasticity and are able to make 
reversible transformations between several phenotypes in response to environmental cues 
(Frid, Dempsey, Durmowicz, & Stenmark, 1997). Each phenotype exhibits its own 
inherent set of physiological properties. Normal mature VSM cells are primarily of the 
contractile type, which contract and relax in response to stimuli (Louis & Zahradka, 
2010). As a consequence of vascular injury and chronic inflammatory states, as seen in 
several diseased states including hypertension (Robinson, Dobbs, & Bayley, 1982), and 
diabetes (McVeigh et al., 1992; Williams, Cusco, Roddy, Johnstone, & Creager, 1996), 
VSM cells undergo transition from the healthy, contractile phenotype to the pathogenic, 
synthetic phenotype (Owens, Kumar, & Wamhoff, 2004). The synthetic phenotype is 
associated with vascular dysfunction, increased migration and proliferation of VSM cells, 
increased vessel constriction, and initiation of lesion formation (Schaper & Ito, 1996; 
Wolf et al., 1998).  The migration and proliferation of VSM cells from the tunica media 
to the tunica intima results in reduced vascular function and is a fundamental process in 
the progression of atherosclerosis (Willis, Pierre-Paul, Sumpio, & Gahtan, 2004).  
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Although only a thin layer of cells, the endothelium functions as a paracrine organ that is 
involved in several physiological functions including participation in immune response, 
inhibition of platelet aggregation and adhesion, and regulation of vascular tone (Corretti 
et al., 2002; Luescher & Barton, 1997; S. Moncada, Radomski, & Palmer, 1988). Certain 
signals sent from the endothelium act directly on the smooth muscle and result in changes 
in vessel tone. Furchgott and Zawadzki (1980) were the first to observe that when 
prepared rabbit aortas were stripped of their endothelial cells, there was diminished VSM 
relaxation in response to the vasodilator acetylcholine. This finding indicates that 
endothelial cells play an imperative role in controlling vascular tone by releasing a 
substance, then named endothelium-derived relaxing factor, which acts on the VSM to 
cause vasodilation. Endothelium-derived relaxing factor was later recognized as the 
short-lived, humoral compound nitric oxide (NO) (Furchgott & Vanhoutte, 1989; Ignarro, 
Buga, Wood, Byrns, & Chaudhuri, 1987; Palmer, Ferrige, & Moncada, 1987). After 
being released from the endothelium in response to shear stress, NO exerts its effects on 
the VSM by increasing the levels of cyclic guanosine monophosphate (cGMP) (S. 
Moncada et al., 1988) 
 
Molecular Mechanism of Vascular Smooth Muscle Relaxation 
NO-mediated VSM relaxation was originally thought to be a cAMP pathway and it was 
not until the 1970’s that it was determined that cGMP was the primary second messenger 
active in the pathway (Carvajal, Germain, Huidobro‐Toro, & Weiner, 2000). This 
pathway is activated when NO binds to the iron-containing prosthetic heme group of 
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soluble guanylyl cyclase (s-GC) (Francis, Busch, Corbin, & Sibley, 2010; Lincoln & 
Cornwell, 1993; E. A. Moncada, 1991). This binding increases the level of cGMP in the 
cell by converting GTP to cGMP (Waldman & Murad, 1988). Increases in cGMP 
concentration activate cGMP-dependent protein kinases, which are a class of 
serine/threonine kinases that are found abundantly in the VSM.  Activated c-GMP-
dependent protein kinases alter intracellular calcium (Ca2+) concentrations through 
several mechanisms including stimulating Ca2+-K+ activated channels, inhibiting Ca2+-
voltage gated channels and activating Ca2+/ATPase pump. Each of these mechanisms 
effectively reduces intracellular Ca2+ levels and results in VSM relaxation.  
 
Endothelium-Independent Dilation 
Celermajer et. al. (1992) described a non-invasive technique to measure endothelium-
independent dilation (EID) that involves the use of ultrasound to monitor changes in 
brachial artery diameter after administration of sublingual nitroglycerin. In vivo, the 
VSM dilates in response to NO released by the endothelium in response to shear stress. 
EID is used as a measure for VSM function (Corretti et al., 2002; Tomiyama & 
Yamashina, 2010) by bypassing the endothelium via direct stimulation of the VSM with 
exogenous nitrovasodilators such as sublingual nitroglycerin (Furchgott & Vanhoutte, 
1989; E. A. Moncada, 1991), which utilizes the same molecular pathway as endogenous 
NO (Francis et al., 2010).  
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A multitude of studies over the years have verified this technique and found that impaired 
EID is associated with several disease states. In a study of 228 adults, Gokce et.al. (2001) 
reported impaired EID in those with hypertension compared with normotensive controls 
(14.9 ± 6.0% versus 18.5 ± 7.8%, p=0.003). In a long-term follow-up study (mean 
follow-up = 6.7 years) of 147 patients (mean age = 54 ± 9.9 years) undergoing vascular 
reactivity function testing, Schachinger, Briteen, & Zeiher (2000) found that those who 
experienced cardiovascular events had a blunted vasodilator response to nitroglycerin and 
the incidence of cardiovascular events was higher in those with lesser nitroglycerin 
response at baseline. Additionally, impaired EID has been observed in those at risk for 
atherosclerotic development but not yet experiencing symptoms. In a study by Adams et. 
al. (1998), 800 asymptomatic subjects (mean age = 38 ± 16 years) were assessed for EID. 
They found that EID negatively correlated with a number of CVD risk factors including 
cholesterol, smoking status, and diabetes. These findings suggest that impaired VSM 
function may be an early indicator of CVD.       
 
Associations of Gender, age and obesity with EID 
Gender 
Males have been shown to have a higher risk of CVD (Lerner et al., 1986) and reduced 
VSM function (Orshal & Khalil, 2004) compared to females. Sex hormones may explain 
these differences as estrogen has been identified as having cardio-protective qualities, 
with premenopausal females demonstrating lower CVD risk than both males and post-
menopausal females (Barrett Connor & Bush, 1991; Mendelsohn, 2002). Additionally, 
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testosterone deficiency in males has been associated with increased risk of CVD along 
with the CVD risk factors of increased plasma triglycerides, obesity, and insulin 
resistance (Jones, 2010; Schooling, 2014; Traish, Saad, Feeley, & Guay, 2009). A study 
using peripheral arterial tonometry, a technique which uses finger plethysmography to 
assess vascular function, assessed EID response in 86 healthy adults after administration 
of 0.4mg of sublingual nitroglycerin. They found that peak nitroglycerin mediated index, 
a calculated index score of EID, was found to be significantly reduced in males compared 
to females (2.50 ± 1.34 versus 3.11 ± 1.59, p = 0.05) (McCue et al., 2012). Additionally, 
a study by Adams et. al. (1998) used regression analysis to evaluate the correlation 
between traditional cardiovascular risk factors, including cholesterol and gender, and 
VSM function by measuring EID response to 0.4mg of sublingual nitroglycerin. In a 
sample of 800 adults, they found that gender was significantly correlated with VSM 
function (r = -0.26, p < 0.001), with males having significantly lower EID values 
compared to females.  
 
In a review by Aggoun, Szezepanski, & Bonnet (2005) they noted that cardiovascular 
function in children and adolescents is impaired by traditional risk factors such as high 
cholesterol, hypertension, and diabetes, similar to reported observations in adults. 
However, there are limited data available on gender differences in EID in children and 
adolescents. Jarvisalo et. al. (2002) administered four doses of 50µg of sublingual 
nitroglycerin, five minutes apart, to assess the dose response curve and EID in 105 
apparently healthy children. Using multiple regression analysis the researchers found that 
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gender was significantly correlated with EID (β = -1.856, p = 0.045) with males reporting 
lower EID response than females. This suggests that differences in VSM function 
between males and females may be distinguishable early in life. 
 
Aging 
Proliferation and migration of VSM cells is a hallmark trait of aging, and therefore leads 
to VSM dysfunction (Lacolley, Regnault, Nicoletti, Li, & Michel, 2012; Rudijanto, 
2007). Some studies have observed reduced EID response in older adults compared with 
younger adults (Montero et al., 2014; Parker, Ridout, & Proctor, 2006). One study 
compared EID in healthy young adults (mean age = 22 ± 1 year, n = 15), healthy older 
adults (mean age = 62 ± 3 years, n = 17) and older adults with diagnosed atherosclerosis 
(mean age = 66 ± 2 years, n = 31) by measuring forearm blood flow via venous occlusion 
plethysmography in response to IV-infused nitroprusside. They found that both healthy 
older adults and atherosclerosis subjects had significantly less EID response than young 
healthy controls (Al-Shaer et al., 2006). However, other studies have reported no 
difference in EID response with age (Heiss et al., 2005; Pierce et al., 2011; K. S. Woo et 
al., 1997). Differences in the results of these studies may be due to the small sample sizes 
and differences in methods used and populations studied.    
 
As with gender differences, there is a dearth of information available on EID and aging in 
children and adolescents. In instances where studies involving youth have reported EID 
values in respect to age, the variable of age has only been utilized as a correcting factor as 
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opposed to a main outcome. One study used multiple linear regression to determine the 
impact of a variety of factors, including age, on EID in youth and reported that age was 
not a significant factor in predicting EID response in this population (β = 0.140, p = 
0.771) (Jarvisalo et al., 2002). This suggests that aging during childhood and adolescents 
may not be profound enough to discern changes in EID.    
 
Tanner staging is a technique used to estimate pubertal status in children and adolescents 
and is based on physical characteristics of sexual maturity, such as pubic hair and breast 
development (Tanner, 1975). Increased insulin resistance during puberty is a well-
documented event that has the potential to influence vascular function (Amiel et al., 
1986; Moran et al., 2002). Chronic insulin resistance, as seen in diabetes, has been 
reported to negatively impact VSM function (Trovati & Anfossi, 2002; Wang, Gurevich, 
& Draznin, 2003). It is possible that the state of insulin resistance during puberty may 
produce similar outcomes as those seen in diabetes and result in reduced EID response. 
Only one study has examined the impact of pubertal status on EID response. In a study 
by Marlatt et al. (2013), 344 children and adolescents were divided by Tanner Stage and 
examined for EID response after administration of 0.3 mg of sublingual nitroglycerin. No 
significant differences were reported in EID between Tanner stages, suggesting sexual 
maturity does not significantly impact VSM function 
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Obesity 
Obesity is frequently accompanied by morbidities such as hypertension and diabetes and 
has been noted to be an independent risk factor for developing CVD (Hubert, Feinleib, 
McNamara, & Castelli, 1983; Zdrojewski et al., 2013). Studies examining EID in respect 
to obesity status in adults are inconclusive as to whether excess weight impacts VSM 
function. Some studies have reported no difference in EID response between obese and 
normal weight individuals (Perticone et al., 2001; Van Guilder, Stauffer, Greiner, & 
Desouza, 2008; Vigili de Kreutzenberg, Kiwanuka, Tiengo, & Avogaro, 2003) while 
others have noted decreased EID in obese subjects (Christou et al., 2012). A study by 
Ayer et. al. (2011) comparing 19 obese adults (mean age = 31.0 ± 1.2 years, mean BMI = 
44.1 ± 2.1 kg/m2) and 19 age-matched normal weight controls (mean BMI = 22.4 ± 0.4 
kg/m2) found those who were obese had lower EID% (13.4 ± 0.9% versus 18.3 ± 1.1%, p 
= 0.002) and EID-AUC (54,316 ± 362 %/s versus 55, 613 ± 375 %/s, p = 0.018) in 
response to incremental doses (total does 500µg) of the vasodilator glyceryl trinitrate.  In 
contrast, Van Guilder et. al. (2008) determined that there was no difference in EID 
between obese (mean BMI = 23.4 ± 0.3 kg/m2) and non-obese subjects (mean BMI = 
30.3 ± 0.6 kg/m2) in response to arterial infusion of sodium nitroprusside.  
 
There is conflicting evidence on the impact of obesity on EID in children and 
adolescents, with some researchers noting differences in EID response between obese and 
non-obese youth (Pena et al., 2006; Tounian et al., 2001) and others finding no significant 
differences (Jarvisalo et al., 2002; K. Woo et al., 2004). One study examining obese 
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(mean BMI = 24.9 ± 4.7 kg/m2) and lean (mean BMI = 15.5 ± 1.5 kg/m2) children (mean 
age = 8.8 ± 1.5 years) found that obese children had significantly lower EID than their 
lean counterparts in response to 300µg of sublingual nitroglycerin (19.0 ± 9.0 versus 25.8 
± 6.1%, p = 0.0014) (Aggoun et al., 2008). This is in contrast to Woo et. al. (2004) who 
reported no difference in EID after sublingual nitroglycerin administration between 
overweight (mean age = 10.9 ± 0.9 years, mean BMI = 26.7 ± 3.0 kg/m2) and age-and-
gender matched controls (mean BMI = 17.1 ± 2.1 kg/m2, 20.6 ± 5.9 versus 19.6 ± 2.8%). 
With no clear association between obesity and EID more research is needed to better 
understand the relationship between these two variables. 
 
VSM dysfunction is characteristic of atherosclerosis, a progressive disease beginning in 
early life. As CVD is the leading the cause of death worldwide (World Health 
Organization, 2013), by examining EID in children and adolescents, who are typically 
free of the progressive effects of aging we are able to examine the effects of obesity and 
other CVD risk factors on vascular smooth muscle function. Therefore, the purpose of 
this study was to examine how gender, age, pubertal status and obesity affect EID 
response in a sample of children and adolescents. 
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Participants 
Data from 322 children and adolescents (142 females), aged 9 to 18 years were used in 
this cross-sectional study (mean age = 14.3 ± 0.22 years; BMI-percentile = 70.0 ± 1.5). 
Data were obtained from two separate cross-sectional studies conducted at the University 
of Minnesota between 2006 and 2011. All studies used the same methods of data 
collection and all were approved by the Institutional Review Board at the University of 
Minnesota.  
 
Anthropometric Measurements 
Height was obtained by use of a standard stadiometer (Ayrton S100, Prior Lake, 
Minnesota) and weight was collected by use of an electric scale (ST Scale-Tronix, White 
Plains, New York). Body mass index (BMI) was calculated as weight in kilograms (kg) 
divided by height in meters-squared (m2). BMI-percentile was calculated using CDC 
normality scales (National Center for Health Statistics (US), 2012) and stratified into 
three categories: normal (>5th percentile - <85th percentile), overweight (≥86th percentile - 
<95th percentile, and obese (≥95th percentile). Two-hundred-sixty-four subjects (119 
females) were assessed for percent body fat, lean mass, and fat mass as determined by 
dual-energy X-ray absorptiometry (DXA) (Lunar Prodigy, General Electric Medical 
Systems) and analyzed using enCoreTM software (platform version 13.6, GE Healthcare, 
Madison, WI, USA). Scans were performed using standard imaging and positioning 
protocol as previously described (Kaul et al., 2012). A sub-group of 266 subjects (121 
females) were assessed by trained providers to determine Tanner stage using previously 
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described protocol (Tanner, 1975). Females were assessed for breast and pubic hair 
development and males were assessed for pubic hair development.   
 
Measurement of Endothelium-Independent Dilation 
Participants were fasted for at least 8 hours, abstained from caffeine and heavy exercise 
for at least 24 hours before their study visit. All data was collected in a quiet, 
temperature-controlled room (22-23oC). Vascular images of the left brachial artery were 
obtained proximal to the antecubital fossa in the longitudinal plane using a conventional 
ultrasound scanner (Acuson, Sequoia 512, Siemens Medical Solutions USA, Inc., 
Mountain View, CA, USA) with a 8-15 MHz linear array probe held at a constant 
pressure on the skin and at a fixed point over the imaged artery by a stereotactic arm. All 
images were digitized and stored for later off-line analysis using electronic wall-tracking 
software (Vascular Research Tools 5, Coralville, IA).  EID measurements were collected 
as previously described (Celermajer et al., 1992) following a 15-minute rest period 
subjects were given 0.3 mg sublingual nitroglycerin to assess EID. Brachial artery 
diameter was measured continuously for 5-minutes post-nitroglycerin administration. 
Peak dilation (EID%) was determined by taking the greatest percent change in artery 
diameter from baseline. Area under the curve (EID-AUC) was defined as the complete 
relaxation of the brachial artery after nitroglycerin administration. 
 
Statistical Analysis 
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Results are presented as mean ± SEM unless otherwise stated. Data was analyzed using 
SAS Software Package (v. 9.4; SAS Inc., Cary, North Carolina). Males and females were 
compared by independent samples t-test for clinical characteristics and chi-square test 
(count, %) for demographic characteristics. The predictors of age, gender, percent body 
fat, BMI-percentile, and baseline diameter were modeled using multiple linear regression. 
Gender-specific regression models were also determined for the dependent variables of 
EID% and EID-AUC using the same predictors. A one-way analysis of variance 
(ANOVA) with Bonferroni post-hoc adjustment was used to assess differences in EID% 
and EID-AUC for gender, Tanner stage and BMI-percentile category with adjustment for 
age, gender, race, and baseline diameter. Significance level was set at α=0.05. 
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CHAPTER 4. RESULTS 
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Participant’s demographic and clinical characteristics, divided by gender, are presented in 
Table 1. Males were significantly taller (p<0.001) and heavier (p=0.03) than females and 
also had greater lean body mass (p<0.001) and lower percent body fat (p<0.001). There 
was a significant relationship between gender and Tanner stage (χ2=14.67, n=266, 
p=0.005), with male gender being associated with lower Tanner stage. Males had a 
significantly lower EID-AUC (3362±146%/s vs 3695±148%/s, p=0.012) but not EID% 
(22.7±0.8% vs 23.8±0.8%, p=0.112) compared to females, after adjustment for age, BMI-
percentile, race, and baseline diameter, as shown in Table 2.  
 
In regression models for both EID% and EID-AUC (Table 3) age was not a significant 
predictor of EID%:(p=0.10) or EID-AUC (p=0.09).  Similarly, BMI-percentile was not a 
significant predictor of EID% (p=0.98) or EID-AUC (p=0.35). Baseline diameter was 
significant in both models (EID%: β=-7.40, p<0.001; EID-AUC: β=-1197.1, p<0.001). 
Gender-specific regression models are represented in Table 4. Age was a significant and 
positive predictor of EID% (β=0.37, p=0.04) and EID-AUC (β=83.5, p=0.02) in females, 
but not in males (EID%: p=0.83; EID-AUC: p=0.92). Greater baseline diameter in both 
females (EID%: β=-8.58, p<0.001; EID-AUC: β=-1384.8, p<0.001) and males (EID%: 
β=-6.57, p<0.001; EID-AUC: β=-1039.8, p<0.001) was associated with a lower EID 
response. One-way ANOVA showed no significant differences between normal-weight, 
overweight, and/or obese participants (Table 5). Additionally, a regression analysis of 
264 subjects (119 females, Table 6) showed that the percent body fat was not a 
significant predictor of EID% (p=0.83) or EID-AUC (p=0.11). A sub-analysis of Tanner 
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stage (266 subjects, 121 females) showed no significant differences in EID% or EID-
AUC between Tanner stages (Table 7).  
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The main findings from the current study reveal that gender may be associated with 
smooth muscle function in children and adolescents, with males having lower EID-AUC, 
but not EID%, compared to females. Gender also appears to impact EID response 
differently across age, with age being a significant and positive predictor of EID in 
females but not in males. Additionally, pubertal status did not have significantly impact 
EID response in our sample. Another main finding of this study is that obesity status, as 
determined by both BMI and body composition based criteria, is not associated with 
smooth muscle dysfunction in children and adolescents. Taken together these data 
suggest that gender may play a role in smooth muscle function in children and 
adolescents independent of body weight and adiposity. 
 
In adults, gender differences in smooth muscle function have been reported with males 
exhibiting lower EID than females (Adams et al., 1998; McCue et al., 2012). The 
difference in EID response between males and females might be explained by the 
hormonal influence of testosterone and estrogen. The influence of testosterone on the 
vascular system is controversial and information from in vivo studies is limited to adult 
samples. In vitro studies have demonstrated conflicting findings, with some reporting 
increases in VSM proliferation and migration in response to testosterone (Campelo, 
Cutini, & Massheimer, 2012; Fujimoto et al., 1994) and others demonstrating 
vasodilation of VSM in response to testosterone (Deenadayalu, White, Stallone, Gao, & 
Garcia, 2001). It may be that testosterone has both positive and negative effects on the 
vascular system, complicating our understanding of how it may contribute to gender 
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differences in EID. In contrast, the influence of estrogen on vascular function has been 
well-studied and has been shown to have cardio-protective properties that directly affect 
vascular smooth muscle function and limit cell migration and proliferation (Akishita et 
al., 1997; White et al., 2002). Studies have shown that in pre-menopausal females, where 
estrogen levels are high, there is a lower incidence of CVD compared to males and post-
menopausal women (Barrett Connor & Bush, 1991; Boukhris et al., 2014). Greater 
estrogen levels in females may explain why females in our study reported significantly 
greater values for EID-AUC than males but not EID%. Estrogen receptors are located on 
the VSM (Mendelsohn & Karas, 1994) and cause K+-channels to open (Mugge, Riedel, 
Barton, Kuhn, & Lichtlen, 1993; White et al., 2002) while also reducing amounts of 
NADPH oxidase, a free radical that degrades NO (Chambliss & Shaul, 2002). These 
influences of estrogen cause VSM relaxation and could extend relaxation time by keeping 
intracellular Ca2+ levels low and increasing bioavailability of NO.  
 
The impact of aging on atherosclerotic development is well documented in adults (Falk, 
2006; Herrera et al., 2010; Rudijanto, 2007). Studies examining EID response in adults 
have determined that, with age, vascular smooth muscle function deteriorates (Al-Shaer 
et al., 2006; Montero et al., 2014). However, the current body of literature examining age 
and EID response in youth is extremely restricted, with most studies using age only as an 
adjustment factor and not as a variable of interest. We observed differences in EID 
response across age between genders, with age being a significant and positive predictor 
of EID in females but not in males. This difference in regression models may be 
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explained by hormonal interactions in cardiovascular function, which are complex and 
differ between genders (Bruck et al., 1997; Traish & Kypreos, 2011). It may be that the 
cardio-protective mechanisms of estrogen and testosterone vary between genders and 
possibly result in gender differing EID response across time.  
 
Another possibility for the difference in multiple linear regression models between 
genders could involve baseline diameter. Males have been noted to have greater baseline 
diameter measurements (Herrington et al., 2001) than females and baseline diameter has 
been previously reported to be inversely related with EID response (Brown, Bolson, 
Petersen, Pierce, & Dodge, 1981; Herrington et al., 2001). It may be that the effect of 
greater baseline diameter could possible overshadow the impact of age on EID in males. 
Our findings support the observation that baseline diameter greatly impacts EID and 
should therefore be adjusted for during statistical analysis. Additionally, we found no 
differences in EID response between Tanner stages. This is in agreement with a study by 
Marlatt et. al.(2013) which reported no difference in EID response between three pubertal 
stage groups: Tanner I, Tanner II-IV, and Tanner V. This suggests that pubertal status 
may not significantly impact EID response and therefore may not be necessary to 
determine during vascular testing.  
 
Information available on the influence of BMI status on EID response is conflicting. 
There are several studies in adults reporting no difference in EID between normal weight 
and obese individuals (Perticone et al., 2001; Van Guilder et al., 2008; Vigili de 
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Kreutzenberg et al., 2003) while other studies contend that there is a difference in EID 
between the groups (Ayer et al., 2011; Christou et al., 2012). This disagreement also 
exists in the pediatric population with some studies reporting differences in EID between 
normal and obese subjects (Aggoun et al., 2008; Pena et al., 2006; Tounian et al., 2001) 
and others reporting no association between EID and BMI (Jarvisalo et al., 2002; K. Woo 
et al., 2004). In the present study, there were no significant differences in EID response 
between normal, overweight and obese children. Additionally, percent body fat was not a 
predictive variable of EID response. This is in agreement with a study by Woo et al. 
(2004), which found no difference in EID response between obese participants and age-
and-gender matched controls. However, a separate study involving a total of 75 
participants reported significantly lower EID response in severely obese subjects 
compared with normal weight controls (Tounian et al., 2001). The mean BMI values for 
obese subjects in this study was greater than the values of our sample. It may be that 
impaired EID response is only detectable in youth who are severely obese, leaving those 
who are overweight/mildly obese unaffected (Fernhall & Agiovlasitis, 2008). 
Furthermore, accounting for baseline diameter, as we did in our analysis, may explain 
differences in results as baseline has been shown to be inversely related to EID% 
(Schroeder et al., 2000). Of the studies examining the relationship between obesity and 
EID in youth, only one reported adjustment for baseline. Using univariate regression, 
Pena et. al. (2006), found that BMI Z-score was significantly correlated with EID. 
However, when baseline diameter was entered into the model, the relationship was no 
longer significant.    
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Strengths of our study include a large sample, with a range of adiposity and age in 
children and adolescents. The inclusion of DXA and Tanner stage data provided accurate 
information on body composition and pubertal development as compared to using age 
and BMI-percentile alone. However, we are limited by the cross-sectional nature of our 
study. While we observed difference in the effect of age on EID between genders in our 
sample, future studies which collect data in a longitudinal manner would be more 
appropriate to examine the trajectory of change in smooth muscle function during youth. 
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In conclusion, we have demonstrated that gender may be associated with smooth muscle 
function in children and adolescents and that differences in EID-AUC between the two 
genders are apparent at an early age. Additionally, resting baseline diameter significantly 
impacts EID response, making it an important variable to adjust for during statistical 
analysis of EID, particularly when comparing males vs. females or normal weight vs. 
obese populations.        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  30 
Table 1. Cohort demographics and anthropometric characteristics. 
 
  Female (n=142) Male (n=180) p-value 
Age (years)  14.3 ± 0.22 13.9 ± 0.19 0.23 
Height (cm)  159.8 ± 0.84 164.6 ± 1.06 <0.001* 
Weight (kg)  58.9 ± 1.43 63.5 ± 1.70 0.03* 
BMI (kg/m2)  22.8 ± 0.43 22.9 ± 0.42 0.83 
BMI-percentile  69.1 ± 2.08 70.8 ± 2.05 0.58 
BMI Z-Score  0.65 ± 0.07 0.76 ± 0.08 0.28 
Percent Body Fat^  29.2 ± 0.92 22.6 ± 1.11 <0.001* 
Lean Mass (kg)^  37.6 ± .8 44.7 ± 1.3 <0.001* 
Fat Mass (kg)^  16.6 ± 1.0 14.2 ± 1.0 0.08 
Race  n (%) n (%) 0.73 
Caucasian  97 (30.2) 123 (38.3)  
Black  32 (10.0) 38 (11.8)  
American Indian  3 (0.9) 5 (1.6)  
Asian/Pacific Islander  3 (0.9) 3 (0.9)  
Other/Mixed  4 (1.3) 2 (0.6)  
Unknown  3 (0.9) 8 (2.5)  
Total  142 179  
Tanner Stage  n (%) n (%) 0.005† 
I  12 (4.5) 30 (11.3)  
II  7 (2.6) 21 (7.9)  
III  15 (5.6) 20 (7.5)  
IV  35 (13.2) 27 (10.2)  
V  52 (19.6) 47 (17.7)  
Total  121 145  
       
Abbreviations: BMI, body mass index; BMI Z-score, body mass index Z-score 
Age, height, mass, BMI, BMI-percentile, BMI Z-score, percent body fat, lean mass and 
fat mass are presented as mean ± SEM. 
Race and Tanner Stage are presented as count (% of total) 
^n = 264 (119 females, 145 males) 
*indicates significance as determined by independent t-test 
 †indicates significance as determined by Chi-squared test 
 
 
 
 
 
 
 
 
  31 
Table 2. EID in males and females. 
 
Gender (n)  Female (142) Male (180) p-value 
EID%     
Mean (%) Unadjusted 26.6 (0.5) 22.5 (0.5) <0.001* 
Adjusted† 23.8 (0.8) 22.7 (0.8) 0.112 
95% CI Unadjusted 25.7, 27.6 21.4, 23.5  
Adjusted† 22.2, 25.4 21.1, 24.2  
EID-AUC     
Mean (%/sec) Unadjusted 4182 (92) 3341 (90) <0.001* 
Adjusted† 3695 (148) 3362 (146) 0.012* 
95% CI Unadjusted 4001, 4363 3163, 3519  
Adjusted† 3404, 3985 3075, 3650  
 
Reported as mean (SE) 
*Indicates significance as determined by ANCOVA analysis with post-hoc Bonferroni 
adjustment 
† Adjusted for race, age, BMI-percentile and baseline diameter 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  32 
Table 3. Multiple linear regression examining the associations of gender, age, 
baseline diameter and BMI-percentile with EID.  
 
Variable β Standard 
Error 
P-value 
EID%    
Baseline Diameter -7.40 0.77 <0.001* 
Gender -1.08 0.71 0.13 
Age 0.23 0.14 0.10 
BMI-percentile 0.0003 0.01 0.98 
EID-AUC    
Baseline Diameter -1197.1 142.5 <0.001* 
Gender -340.0 132.1 0.01* 
Age 44.1 25.9 0.09 
BMI-percentile 2.2 2.3 0.35 
 
*Denotes significance as determined by multiple linear regression 
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Table 4. Multiple linear regression examining the associations of age, baseline diameter and 
BMI-percentile with EID by gender.  
 
   Females    Males  
Variable  β Standard 
Error 
P-value  β Standard 
Error 
P-value 
EID%         
Baseline Diameter  -8.58 1.30 <.001  -6.57 1.05 <0.001 
Age  0.37 0.17 0.038  0.05 0.22 0.83 
BMI-percentile  0.003 0.018 0.887  -0.005 0.02 0.79 
EID-AUC         
Baseline Diameter  -1384.8 250.3 <.001  -1039.8 187.9 <0.001 
Age  83.5 33.7 0.015  -3.7 39.6 0.92 
BMI-percentile  -0.45 3.4 0.894  3.2 3.1 0.30 
 
*Denotes significance as determined by multiple linear regression 
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Table 5. EID according to obesity status. 
 
BMI Category (n) Normal (181) Overweight (78) Obese (59) 
EID%    
Mean (%) Unadjusted 24.9 (0.5) 24.2 (0.7) 22.7 (0.9) 
Adjusted† 24.3 (0.4) 24.7 (0.6) 24.4 (0.8) 
95% CI Unadjusted 23.9, 25.9 22.8, 25.6 20.8, (24.5) 
Adjusted† 23.4, 25.1 23.4, 25.9 22.9, 25.9 
EID-AUC     
Mean (%/sec) Unadjusted 3765 (91) 3438 (172) 3859 (130) 
Adjusted† 3652 (78) 3940 (119) 3766 (138) 
95% CI Unadjusted 3585, 3945 3600, 4119 3094, 3782 
Adjusted† 3499, 3805 3707, 4174 3495, 4036 
 
Reported as mean (SE) 
† Adjusted for gender, race, age, and baseline diameter 
No significant differences found between groups prior to and after adjustment (p-value > 
0.05) 
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Table 6. Multiple linear regression examining the associations of gender, 
age, baseline diameter and percent body fat with EID.  
 
Variable β Standard Error P-value 
EID%    
Baseline diameter -8.61 1.15 <0.001* 
Gender -0.58 1.04 0.52 
Age 0.23 0.23 0.38 
Percent body fat -0.02 0.04 0.63 
EID-AUC    
Baseline diameter -1455.2 195.0 <0.001* 
Gender -181.4 177.6 0.31 
Age 66.4 38.8 0.09 
Percent body fat 8.5 8.3 0.31 
 
                  *Indicates significance as determined by multiple linear regression 
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Table 7. EID measures by Tanner Stage. 
 
Tanner Stage (n)  Stage I (42) Stage II (28) Stage III (35) Stage IV (62) Stage V (99) 
EID%       
Mean (%) Unadjusted 26.4 (1.3) 25.0 (1.1) 23.7 (1.0) 24.4 (0.7) 24.1 (0.7) 
Adjusted† 23.1 (1.5) 22.7 (1.4) 23.2 (1.0) 24.7 (0.7) 26.3 (1.0) 
95% CI Unadjusted 23.7, 29.1 22.7, 27.3 21.6, 25.8 22.9, 25.9 22.7, 25.56 
Adjusted† 20.1, 26.1 19.9, 25.5 21.2, 25.2 23.2, 26.1 24.4, 28.2 
EID-AUC       
Mean (%/sec) Unadjusted 4031 (208) 3814 (209) 3506 (181) 3833 (147) 1305 (126) 
Adjusted† 3423 (274) 3419 (261) 3407 (185) 3842 (133) 4135 (174) 
95% CI Unadjusted 3611, 4450 3406, 4292 3139, 3874 3503, 4099 3474, 4006 
Adjusted† 2882, 3964 2903, 3934 3043, 3771 3580, 4103 3793, 4478 
 
Reported as mean (SE) 
† Adjusted for gender, race, age, BMI-percentile and baseline diameter 
No significant differences found between groups prior to and after adjustment (p-value > 0.05)
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